PL377695A1 - Sinomenina i związki synomeniny, synteza i zastosowanie - Google Patents
Sinomenina i związki synomeniny, synteza i zastosowanieInfo
- Publication number
- PL377695A1 PL377695A1 PL377695A PL37769503A PL377695A1 PL 377695 A1 PL377695 A1 PL 377695A1 PL 377695 A PL377695 A PL 377695A PL 37769503 A PL37769503 A PL 37769503A PL 377695 A1 PL377695 A1 PL 377695A1
- Authority
- PL
- Poland
- Prior art keywords
- sinomenine
- synthesis
- compounds
- sinomenine compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021538190A CN1328280C (zh) | 2002-11-28 | 2002-11-28 | 汉防己碱和汉防己碱化合物,合成和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL377695A1 true PL377695A1 (pl) | 2006-02-06 |
Family
ID=32331921
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377695A PL377695A1 (pl) | 2002-11-28 | 2003-11-26 | Sinomenina i związki synomeniny, synteza i zastosowanie |
Country Status (15)
Country | Link |
---|---|
US (1) | US20060009480A1 (pl) |
EP (1) | EP1565444A1 (pl) |
JP (1) | JP2006509755A (pl) |
KR (1) | KR100706462B1 (pl) |
CN (2) | CN1328280C (pl) |
AU (1) | AU2003290119A1 (pl) |
BR (1) | BR0316609A (pl) |
CA (1) | CA2507067A1 (pl) |
EA (1) | EA200500862A1 (pl) |
MA (1) | MA27573A1 (pl) |
MX (1) | MXPA05005687A (pl) |
NO (1) | NO20053139L (pl) |
PL (1) | PL377695A1 (pl) |
WO (1) | WO2004048340A1 (pl) |
ZA (1) | ZA200504055B (pl) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1298720C (zh) * | 2005-03-18 | 2007-02-07 | 中国科学院上海有机化学研究所 | C环连接有五元杂环的青藤碱衍生物和合成方法 |
CN1298718C (zh) * | 2005-03-18 | 2007-02-07 | 中国科学院上海有机化学研究所 | C环连接有吡嗪环的青藤碱衍生物、合成方法及其用途 |
CN100455571C (zh) * | 2005-12-09 | 2009-01-28 | 湖南正清制药集团股份有限公司 | 青藤碱盐化合物及其制备方法 |
EP1959956A2 (en) * | 2005-12-15 | 2008-08-27 | Naturemed Group Corporation | Sinomenine derivatives and preparation and uses thereof |
CN101578101B (zh) * | 2005-12-15 | 2012-05-23 | 自然医学公司 | 青藤碱衍生物的制备和应用 |
CN100408578C (zh) * | 2006-03-15 | 2008-08-06 | 南京大学 | 一类17-酰基青藤碱衍生物及其制备方法 |
CN101092397B (zh) * | 2006-06-19 | 2011-01-19 | 湖南正清制药集团股份有限公司 | 一种青藤碱结构改造化合物及其制备方法 |
CN1876634A (zh) * | 2006-06-19 | 2006-12-13 | 湖南正清制药集团股份有限公司 | 一种青藤碱结构改造化合物及其制备方法 |
US20070290378A1 (en) * | 2006-06-20 | 2007-12-20 | International Business Machines Corporation | Novel reworkable underfills for ceramic mcm c4 protection |
CN100396686C (zh) * | 2006-08-03 | 2008-06-25 | 西安皓天生物工程技术有限责任公司 | 一种汉防己甲素和汉防己乙素的制备方法 |
CN102093373A (zh) * | 2007-06-19 | 2011-06-15 | 湖南正清制药集团股份有限公司 | 一种青藤碱结构改造化合物及其制备方法 |
NZ611651A (en) | 2007-12-17 | 2014-11-28 | Mallinckrodt Llc | Sinomenine derivatives and processes for their synthesis |
EP2398806A1 (en) * | 2009-02-23 | 2011-12-28 | Mallinckrodt LLC | (+)-morphinanium n-oxides and processes for their production |
EP2340832A1 (en) * | 2009-12-23 | 2011-07-06 | Universität Innsbruck | Morphinan-6-one compounds for the treatment or prevention of neurodegenerative diseases |
CN101798285B (zh) | 2010-02-10 | 2012-05-23 | 中国科学院上海有机化学研究所 | 一种青藤碱衍生物、合成方法及其用途 |
CN101899004A (zh) * | 2010-06-24 | 2010-12-01 | 江苏大学 | 青藤碱衍生物、制备方法及其医药用途 |
CN101948430A (zh) * | 2010-09-01 | 2011-01-19 | 南京大学 | 青藤碱衍生物及其制备方法和应用 |
CN102532024B (zh) * | 2011-12-28 | 2016-08-03 | 赵爱国 | 青藤碱衍生物 |
CN104306954B (zh) * | 2014-09-25 | 2016-08-24 | 中山大学 | Wry三肽在制备治疗阿尔茨海默症药物中的用途 |
CN104258371B (zh) * | 2014-09-25 | 2016-06-15 | 中山大学 | Www三肽在制备治疗阿尔茨海默症药物中的用途 |
CN104258372B (zh) * | 2014-09-25 | 2017-01-25 | 中山大学 | Rgd三肽在制备治疗阿尔茨海默症药物中的用途 |
CN104274817B (zh) * | 2014-09-25 | 2016-06-15 | 中山大学 | Wrw三肽在制备治疗阿尔茨海默症药物中的用途 |
EP3414437A4 (en) | 2016-02-10 | 2020-04-29 | Pilaar, James Gray | IMPROVED INFLATABLE ACOUSTIC MITIGATION SYSTEM |
CN107648179A (zh) * | 2017-09-21 | 2018-02-02 | 浙江中医药大学 | 一种治疗类风湿性关节炎的新型皮肤给药制剂及其制备方法 |
CN108704640B (zh) * | 2018-06-13 | 2021-03-30 | 绍兴市梓昂新材料有限公司 | 一种多孔氧化铂催化剂的制备方法 |
CN110433132B (zh) * | 2019-08-19 | 2023-06-30 | 中国人民解放军军事科学院军事医学研究院 | 治疗创伤后应激障碍的粉防己碱鼻用制剂 |
CN113880764B (zh) * | 2020-07-01 | 2023-04-18 | 北京师范大学 | 青藤碱衍生物及其制备方法与应用 |
CN114831990A (zh) * | 2022-03-22 | 2022-08-02 | 台州恩泽医疗中心(集团) | 青藤碱在制备治疗帕金森病药物组合物中的应用 |
CN115260098B (zh) * | 2022-06-09 | 2024-06-04 | 澳门科技大学 | Abcb5抑制剂在制备多耐药性类风湿性关节炎治疗药物中的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4912114A (en) * | 1988-03-18 | 1990-03-27 | Sandoz Ltd. | Morphinan derivatives |
KR100341950B1 (ko) * | 1993-07-19 | 2002-11-29 | 도레이 가부시끼가이샤 | 뇌세포보호제 |
US6372756B1 (en) * | 1998-02-20 | 2002-04-16 | Avmax, Inc. | Epimorphian compound and its use |
-
2002
- 2002-11-28 CN CNB021538190A patent/CN1328280C/zh not_active Expired - Fee Related
-
2003
- 2003-11-26 JP JP2004554526A patent/JP2006509755A/ja active Pending
- 2003-11-26 CN CNA200380104606XA patent/CN1720232A/zh active Pending
- 2003-11-26 MX MXPA05005687A patent/MXPA05005687A/es not_active Application Discontinuation
- 2003-11-26 PL PL377695A patent/PL377695A1/pl unknown
- 2003-11-26 EP EP03782481A patent/EP1565444A1/en not_active Withdrawn
- 2003-11-26 CA CA002507067A patent/CA2507067A1/en not_active Abandoned
- 2003-11-26 BR BR0316609-0A patent/BR0316609A/pt not_active IP Right Cessation
- 2003-11-26 AU AU2003290119A patent/AU2003290119A1/en not_active Abandoned
- 2003-11-26 WO PCT/EP2003/014841 patent/WO2004048340A1/en active Application Filing
- 2003-11-26 EA EA200500862A patent/EA200500862A1/ru unknown
- 2003-11-26 KR KR1020057009584A patent/KR100706462B1/ko not_active IP Right Cessation
- 2003-11-26 US US10/536,613 patent/US20060009480A1/en not_active Abandoned
-
2005
- 2005-05-19 ZA ZA200504055A patent/ZA200504055B/en unknown
- 2005-06-27 NO NO20053139A patent/NO20053139L/no not_active Application Discontinuation
- 2005-06-27 MA MA28362A patent/MA27573A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
CN1504469A (zh) | 2004-06-16 |
EA200500862A1 (ru) | 2005-12-29 |
WO2004048340A1 (en) | 2004-06-10 |
EP1565444A1 (en) | 2005-08-24 |
NO20053139L (no) | 2005-06-27 |
ZA200504055B (en) | 2006-08-30 |
US20060009480A1 (en) | 2006-01-12 |
BR0316609A (pt) | 2005-10-11 |
CN1328280C (zh) | 2007-07-25 |
JP2006509755A (ja) | 2006-03-23 |
CA2507067A1 (en) | 2004-06-10 |
KR20050071712A (ko) | 2005-07-07 |
KR100706462B1 (ko) | 2007-04-10 |
MXPA05005687A (es) | 2005-08-16 |
MA27573A1 (fr) | 2005-10-03 |
WO2004048340A8 (en) | 2005-07-07 |
CN1720232A (zh) | 2006-01-11 |
AU2003290119A1 (en) | 2004-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL377695A1 (pl) | Sinomenina i związki synomeniny, synteza i zastosowanie | |
PL372902A1 (pl) | Nowe zastosowanie | |
GB0206048D0 (en) | Use | |
GB0227666D0 (en) | Use | |
GB0220214D0 (en) | Compounds and their use | |
GB0217056D0 (en) | Use | |
GB0213878D0 (en) | Use | |
GB0206838D0 (en) | Use | |
HK1077823A1 (en) | Acutumine and acutumine compounds, synthesis and use | |
GB0227906D0 (en) | Compounds and their use | |
GB0230343D0 (en) | Use | |
GB0204720D0 (en) | Novel use | |
GB0210682D0 (en) | Novel use | |
GB0218031D0 (en) | Compounds and their use | |
GB0229442D0 (en) | Use | |
GB0204510D0 (en) | Improved synthesis | |
SE0203089D0 (en) | New use | |
GB0223720D0 (en) | New use | |
GB0200531D0 (en) | New use | |
GB0204610D0 (en) | New use | |
GB0200737D0 (en) | New use | |
GB0203207D0 (en) | New use | |
GB0218422D0 (en) | New use | |
GB0200581D0 (en) | Security holder | |
GB0207228D0 (en) | Use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |